Arbutus Biopharma Corp (ABUS ፦ ) የአክሲዮን ዋጋ እና ዜና

መነሻABUS • NASDAQ

Arbutus Biopharma Corp

$4.26

ማርች 16, 8:20:34 ጥዋት ጂ ኤም ቲ-4 · USD · NASDAQ · ተጠያቂነትን ማንሳት

ክምችትበዩናይትድ ስቴትስ የተዘረዘረ ደህንነትዋና መስሪያ ቤቱ ዩናይትድ ስቴትስ ውስጥ የሆነ

የቀዳሚ መዝጊያ

$4.26

የዓመት ክልል

$2.71 - $5.10

የገበያው አጠቃላይ ዋጋ

819.30 ሚ USD

አማካይ መጠን

2.67 ሚ

የዋጋ/ገቢ ምጥጥን

የትርፍ ክፍያ

ዋና ልውውጥ

NASDAQ

የገበያ ዜና

Yahoo Finance

ከ16 ደቂቃዎች በፊት

JFB (NASDAQ: JFB) Announces XTEND and Rayonix Execute Exclusive Manufacturing and Distribution Agreement with Initial $11 Million Commitment to Expand XOS Platform into India.

Fresno Bee

ከ38 ደቂቃዎች በፊት

New to The Street Broadcasts Episode Featuring FreeCast (NASDAQ:CAST), KLED.AI, PetVivo (OTCQB:PETV), EmpowerLit, and BlackBarn NYC on Bloomberg Television - March 21 at 6:30 PM EST

Quipt Home Medical (NASDAQ: QIPT) delists common shares via Form 25

Trump has 15 days to end the Iran war or markets face a brutal April repricing — from oil to the S&P 500

Severe oil shock could drag S&P 500 down to 5,400, Goldman warns

How do companies get added to (& dropped from) the Dow? The averages committee explained

.DJI

0.00%

ስለ

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia

ዋና ሥራ አስፈጻሚ

William H. Collier

የተመሰረተው

2007

ዋና መሥሪያ ቤት

Warminster Township፣ ፔንስልቬኒያ
ዩናይትድ ስቴትስ

ድህረገፅ

arbutusbio.com

ሠራተኞች